The human apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, or hA3G) protein, provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contain one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs). We have constructed secondary structure models of the APOBEC proteins through a combination of structure prediction and subsequent alignment with nucleotide CTDAs whose structures have been solved to high resolution. Secondary structure elements common to all CTDAs are predicted, in addition to structural features that are apparently unique to the APOBEC family of proteins. Most notably, a putative looped-out helix abuts an amino acid that modulates the susceptibility of A3G proteins to the antagonistic action of the human and simian immunodeficiency virus (HIV and SIV) Vif proteins. Using the structure models as a guide, we reflect on mutagenesis studies of the APOBEC1 (A1), hA3G and activation induced deaminase (AID) proteins, with emphasis on the determinants of cytidine deamination and antiviral activities. D
APOBEC proteins in antiviral defence
In recent years, a novel intracellular defence mechanism against retroviral infection has been identified. This discovery provided an explanation for the observation that the HIV Vif (viral infectivity factor) protein is required for viral replication in certain cell types, termed non-permissive (e.g., primary CD4 T lymphocytes), but not in others, termed permissive. In particular, non-permissive cells were found to express a protein, hA3G (formerly called CEM15), that potently suppresses the infectivity and replication of vifdeficient HIV (Sheehy et al., 2002) . The presence of hA3G in virus-producing cells results in its incorporation into virions, and in cytidine (C) to uridine (U) deamination of mostly minus strand (or first strand) reverse transcripts: such mutations register as guanosine (G) to adenosine (A) transitions in plus stranded DNA Lecossier et al., 2003; Mangeat et al., 2003; Zhang et al., 2003) . Because mutational (or editing) frequencies can exceed 10% of all G residues, this phenomenon is termed hypermutation. In addition to the inactivation of viral genetic elements through hypermutation, reduced accumulation of viral cDNAs has been noted for Dvif infections carried out in the presence of hA3G (Mangeat et al., 2003; Simon and Malim, 1996) . The Vif protein prevents this mutational onslaught by binding to hA3G and recruiting a ubiquitin ligase such that hA3G is degraded by the proteasome and excluded from budding virions (Conticello et al., 2003; Mariani et al., 2003; Marin et al., 2003; Mehle et al., 2004; Sheehy et al., 2003; Stopak et al., 2003; Yu et al., 2003 Yu et al., , 2004b .
The antiviral activity of hA3G extends well beyond HIV and, to date, has been shown to target a variety of substrates including other retroviruses such as various SIVs, equine infectious anaemia virus (EAIV) and murine leukaemia virus (MLV) (Gaddis et al., 2004; Harris et al., 2003; Mangeat et al., 2003; Mariani et al., 2003) as well as the hepadnavirus HBV (Rosler et al., 2004; Turelli et al., 2004) . The hA3G gene is located on chromosome 22, where it is flanked by genes coding for highly related proteins named APOBEC3A through H Jarmuz et al., 2002) . Of these, APOBEC3F (hA3F) and APOBEC3B (hA3B) also possess antiviral activity against HIV (Bishop et al., 2004a; Liddament et al., 2004; Wiegand et al., 2004; Zheng et al., 2004) , whereas hA3B and APOBEC3C (hA3C) can inhibit certain SIV isolates (Yu et al., 2004a) . Two rodent family members, mouse APOBEC3 (mA3) and rat APOBEC1 (rA1), also possess potent anti-HIV activity when expressed in human cells (Bishop et al., 2004a (Bishop et al., , 2004b Mariani et al., 2003) . Perhaps somewhat surprisingly, mA3 does not inhibit infection by the murine retrovirus, MLV (Bishop et al., 2004a) .
The APOBEC3 proteins belong to a family of polynucleotide CTDAs that further includes APOBEC1 (A1), APO-BEC2 (A2) and activation induced deaminase (AID) (Conticello et al., 2005; Harris and Liddament, 2004; Jarmuz et al., 2002) . A1, the founder member, is expressed in human gastrointestinal tissues and specifically edits C 6666 in apolipoprotein B mRNA to generate a premature stop codon (Teng et al., 1993) . AID is expressed in B cells and is essential for both somatic hypermutation and class switch recombination during antibody gene diversification; most groups consider both processes to be initiated through C-to-U editing of DNA at the immunoglobulin loci (Lee et al., 2004) . A2 is expressed most prominently in cardiac and skeletal muscle (Liao et al., 1999) , but its function is currently unknown.
Structures of nucleotide CTDAs
All members of the APOBEC protein family contain one or two copies of a His/Cys-X-Glu-X 23-28 -Pro-Cys-X 2 -Cys signature motif that is characteristic of CTDAs. In the case of A1, there is good agreement that disruption of the highly conserved residues abolishes both nucleic acid binding and RNA editing (MacGinnitie et al., 1995; Navaratnam et al., 1995; Teng et al., 1999; Yamanaka et al., 1994) , and mutation of the Glu residue has been shown to abolish the DNA mutator activity of AID .
Crystal structures for nucleotide CTDAs from Escherichia coli (Betts et al., 1994) , Bacillus subtilis (Johansson et al., 2002) , Saccharomyces cerevisiae (Xie et al., 2004) and most recently humans (Chung et al., 2005) are available. These structures reveal a core h 1 h 2 a 1 h 3 a 2 h 4 h 5 arrangement in which the five h-strands form a mixed sheet that supports the parallel positioning of two a-helices that contain the His, Cys and Glu residues that are required for zinc-coordination, proton transfer and catalysis (Fig. 1A) (Wedekind et al., 2003) . The availability of this information together with the sequences of more than ten APOBEC proteins offers an opportunity to perform homology modeling. Since no APOBEC protein structure has yet been determined, such analyses may provide clues as to common trends and differences among the organizations of APOBEC family members. Structural insight into the APOBEC proteins is of considerable interest not only from the perspective of basic biological understanding, but also for future rational drug design efforts.
Homology structure models based on E. coli or yeast nucleotide CTDAs have previously been proposed for A1, AID and hA3G (Navaratnam et al., 1998; Schrofelbauer et al., 2004; Ta et al., 2003; Wedekind et al., 2003; Xie et al., 2004; Zaim and Kierzek, 2003) . In general, these models were derived by alignment of the His/Cys-X-Glu-X 23-28 -Pro-Cys-X 2 -Cys motif and subsequent fitting of the APOBEC amino acid sequence onto the CTDA structure. Intriguingly, these models show little similarity outside of the catalytic core, which may be due to different consid- Fig. 1 . Structures of the cytidine deaminase catalytic domain. (A) Nucleotide CTDAs show a consensus h 1 h 2 a 1 h 3 a 2 h 4 h 5 motif that forms a mixed h-sheet which supports the proper positioning of the a-helices that contain the catalytic and zinc-coordinating residues. (B) Between h 4 and h 5 , APOBEC proteins all contain an insert that is predicted to fold into an a-helical structure, a 3 . In A3G, this helix is adjacent to residue 128 that is associated with the species-specific interaction with Vif. a-Helices are shown in yellow and h-strands in pink. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) erations being applied at the fitting step of the modeling. Because there are considerable differences in the lengths and sequences of the APOBEC and nucleotide CTDA proteins, alignment of the sequences is, indeed, all but straightforward.
Computer-assisted structure predictions
As an alternative approach to APOBEC protein structure prediction, we performed computer-assisted secondary structure predictions using the SAM-T02 package, which predicts elements of protein structure from the amino acid sequence Karplus et al., 2001 Karplus et al., , 2003 . In contrast to the predictions noted above, this analysis avoids the ambiguity of how to fit the APOBEC polypeptides onto the backbone of CTDA structures. For all our analyses, we limited the predictions to a-helices and h-strands. As an initial validation of this approach, we analyzed the four nucleotide CTDA sequences for which structures are known; close agreement between predicted and actual a-helices and h-strands was found in all cases. Except for one 2-residue h-strand (E. coli) and one 4-residue a-helix (B. subtilis), all structural elements were correctly identified. The overall accuracy of prediction was 72% for any given residue, with most of the error being caused by modest overestimations in the length of a-helices or h-strands. The process was then repeated for a total of 17 APOBEC proteins, and some of the results are depicted in Fig. 2 , where predicted ahelices and h-strands of the APOBEC proteins are aligned with crystallography-derived secondary structures of nucleotide CTDA enzymes by a combination of sequence and structural similarity. This approach immediately revealed the prediction of a 1 , h 3 , a 2 and h 4 throughout the APOBEC family of proteins. This was not unexpected since this region harbors the catalytic core and therefore suggests that this central part of the CTDA fold is structurally well conserved between nucleotide and polynucleotide CTDAs.
The amino-terminus
The identification of candidates for h 1 , h 2 and h 5 proved less obvious among the APOBEC proteins. The N-terminal regions preceding a 1 showed a strong prediction for one hstrand flanked by two weaker predicted h-strands. In the hsheet of the CTDA fold, h 1 is centrally located between h 2 and h 3 , and h 2 provides a turn at the edge of the structure (Fig. 1A) . Reasoning that h 1 may be more constrained due to its central position in the CTDA fold, we assigned the second and third h-strands to correspond with h 1 and h 2 , respectively. We note that this assignment is tentative only and that the extent of the predicted h 2 strand is limited. One particularly complicating factor is the prediction of an ahelix for A1 at the presumed position of h 1 . Because structure prediction is more accurate when shorter amino acid sequences are analyzed, we next repeated the procedure using a series of truncated A1 sequences from human, rat and mouse. Two h-strands that may correspond to h 1 and h 2 were predicted, when these shortened sequences were analyzed (Fig. 3) .
APOBEC CTDA domains contain an additional a-helix
Perhaps the most striking difference between the predicted secondary structures of APOBEC proteins and the established structures of nucleotide CTDA proteins occurs C-terminal to h 4 . Whereas the nucleotide CTDA h 4 is followed by a turn and then h 5 the APOBEC proteins are predicted to have an intervening a-helix. Since the h 5 -strands of the APOBEC proteins share sequence similarity with the h 5 regions of the nucleotide CTDA molecules (Fig. 2) , we propose that the APOBEC proteins have acquired an insert between h 4 and h 5 that may take the form of a looped-out helix (Fig. 1B) . We have encountered this feature in all known APOBEC proteins (not shown), suggesting that it may be a defining element of the family.
Of particular interest is the fact that a critical amino acid residue in A3G proteins that constrains species-specific interactions with Vif has been mapped to this region. SIVs and HIVs encode divergent Vif proteins that induce the proteolytic degradation of cognate simian or human A3G proteins through the recruitment of cellular ubiquitin ligase complexes (Liu et al., 2004; Yu et al., 2003) . A single amino acid difference at position 128 -aspartic acid in human versus lysine in African green monkey (AGM) A3G (Fig. 2) confers susceptibility to HIV or SIVagm Vif, respectively Mangeat et al., 2004; Schrofelbauer et al., 2004; Xu et al., 2004) . We infer that the positioning of this residue adjacent to an exposed a-helix renders it ideal for participating in the direct interaction with Vif (or other unknown regulatory factors).
The two CTDA domains of hA3G
Based on the points summarized above, we predict that the CTDA fold of APOBEC proteins conform to a h 1 h 2 a 1 h 3 a 2 h 4 a 3 h 5 arrangement rather than the h 1 h 2 a 1 h 3 a 2 h 4 h 5 arrangement seen in the nucleotide CTDA enzymes (Fig. 1) . We emphasize, however, that while this model is a useful starting point for assigning potential activities or attributes to regions of APOBEC proteins (discussed further below), it leaves much to be explained in terms of the specific functions of APOBEC CTDA domains, and the differences between domains.
hA3B, hA3F and hA3G all have two CTDA domains that could contribute differentially to substrate recognition (e.g., RNA versus DNA) and target site sequence preferences. Based on structure predictions and the conservation of the His/Cys-X-Glu-X 23-28 -Pro-Cys-X 2 -Cys motif (Fig. 2) , it might have been predicted that each domain would mediate cytidine deamination during retrovirus infection. This issue has recently been addressed by substituting the conserved Fig. 2 . Alignment of predicted APOBEC protein structures with crystallography derived structures of cytidine deaminases. Predicted APOBEC protein structures: human activation induced deaminase (AID), human APOBEC1 (A1), human APOBEC2 (A2) and human APOBEC3G (A3G). As hA3G has a duplicated primary structure, the sequence has been divided into N-and C-terminal domains (A3G-N and A3G-C, respectively), although the prediction was performed with the entire amino acid sequence. Predictions of the APOBEC structures were generated using the SAM-T02 package. Four different outputs were generated for each sequence; a given residue was only assigned to an a-helix or h-strand when it was predicted in three out of four cases. Crystallography derived secondary structures (Kabsch and Sander, 1983) of nucleotide CTDAs are from human, Saccharomyces cerevisiae (yeast), Bacillus subtilis and Escherichia coli. Crystallographic data derived from cytosine deaminases were not included as these enzymes have significantly different structures. a-Helices are shown in yellow and h-strands in pink. Catalytic residues are indicated in bold and the 128 residue in hA3G that governs the species-specific interaction with Vif is boxed. Structural elements of the E. coli pseudocatalytic domain are indicated with an asterisk. In addition to the sequences shown, the following APOBEC proteins were also analyzed in the same way: chicken and zebrafish AID; rat, mouse, rabbit and hamster A1; rat and mouse A2; human A3 A, B, C and F; African green monkey A3G. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) His, Cys or Glu residues in either the N-or C-terminal CTDA domains or both of hA3G (Newman et al., 2005) . Unexpectedly, whereas only one of the domains needs to be intact to achieve anti-HIV activity in a tissue culture model of infection, with no preference as to which one, an intact Cterminal CTDA domain is essential for cytidine deamination. Thus, the two CTDA domains of hA3G are not equivalent to each other, with only the C-terminal domain appearing to be catalytically active. This indicates that viral DNA editing is not always required for the antiviral activity of hA3G. These findings are also in keeping with an hA3G-mediated antiviral activity against HBV that does not require cytidine deamination (Rosler et al., 2004; Turelli et al., 2004) , and indicate that APOBEC proteins can confer anti-viral phenotypes by a mechanism distinct from hypermutation. Interestingly, this separation of activities is somewhat reminiscent of the segregation of somatic hypermutation from class switch recombination seen for certain mutant forms of AID (Barreto et al., 2003; Shinkura et al., 2004; Ta et al., 2003) .
The pseudocatalytic domain
Our alignment additionally highlights the structural divergence of the E. coli CTDA from other nucleotide CTDAs. This enzyme is active as a dimer and the Cterminal sequence is structurally similar to the CTDA fold but lacks the catalytic residues. Accordingly, this region has been termed the pseudocatalytic domain and it provides the dimeric E. coli protein with a quaternary structure that is equivalent to the tetrameric organization of the B. subtilis, S. cerevisiae and human CTDAs (Johansson et al., 2002) . Based on our analysis, none of the APOBEC proteins appear to contain a domain that is equivalent to the pseudocatalytic domain, suggesting that the E. coli CTDA is an unsuitable template for inferring the structural organization of APOBEC proteins. There is some evidence to suggest that hA3B, hA3F and hA3G form homo-and heterodimers (Jarmuz et al., 2002; Shindo et al., 2003; Wiegand et al., 2004) . However, since these proteins have a duplicated CTDA domain, one would expect the assembled dimers to actually resemble the tetrameric structure with four active sites and four coordinated zinc ions. This furthermore suggests that APOBEC proteins with single CTDA domains will assemble into tetramers.
Carboxy-terminal leucine-rich regions
The APOBEC proteins show an organization of their C-terminal sequences that is distinctly different from the pseudocatalytic domain of the E. coli CTDA. Specifically, these regions are leucine-rich and are predicted to contain significant amounts of a-helix (Fig. 2) . These features are commonly found in protein domains involved in proteinprotein interactions, and there is evidence to support that this is the case with A1 and AID. First, mutations and deletions within the C-terminal domain of A1 do not affect deamination activity but do compromise multimerization, co-factor binding and nuclear distribution (MacGinnitie et al., 1995; Teng et al., 1999; Yamanaka et al., 1994; Yang et al., 1997 Yang et al., , 2001 ). Second, C-terminal mutations in AID can yield proteins that remain competent for triggering somatic hypermutation but are defective for classswitch recombination and normal nuclear distribution (Barreto et al., 2003; Bransteitter et al., 2004; Brar et al., 2004; Ito et al., 2004; Shinkura et al., 2004; Ta et al., 2003) . In both cases, protein-protein interactions have been implied, either directly or indirectly, to account for these effects. Importantly, these studies demonstrate functional segregation of APOBEC C-terminal domains from elements essential for deamination activity: this is consistent with our current prediction that this region is not part of the CTDA motif.
Summary
We have presented structure models for APOBEC proteins that were generated by computational prediction and subsequent alignment with known CTDA structures. Interestingly, most structural elements common to CTDAs were readily identified in APOBEC proteins. One apparently unique feature of the APOBEC proteins is the presence of a predicted a-helix between two h-strands of the canonical CTDA fold. Since the species-specific interaction of Vif with A3G proteins is dependent on this Fig. 3 . Structure prediction with truncated APOBEC1 sequences from human, rat and mouse. Structure predictions were performed on sequences as they are shown. Although an a-helix is predicted in this region when the whole amino acid sequences are used, analysis of truncated sequences permits prediction of hstrands. a-Helices are shown in yellow and h-strands in pink. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) region, we propose that this element has the potential to serve as a binding site for co-factors that may modulate APOBEC protein function. The C-terminal sequences of APOBEC proteins also contain a-helices that appear structurally distinct from the core CTDA domain and may be optimally suited for protein-protein interactions. Indeed, disruptions in this region are known to interfere selectively with the class switch recombination function of AID, but not with the induction of somatic hypermutation. By analogy, it will be interesting to see how helical regions C-terminal to the conserved CTDA folds of hA3G may participate in biological activity, particularly with respect to the editing-independent antiviral activity.
